The BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.
The Rapid Response™ antigen test device is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 lockdowns.
Used as part of a comprehensive rapid testing program for COVID-19, the BTNX nasal device offers fast, easy-to-use, and reliable screening. Testing all staff 1-2 times/week help detect the virus early and decrease the likelihood of spreading COVID-19.
- Time to results: 15 minutes
- Specimen: nasal swabs
- Format: cassette
- Storage conditions: 2-30°C/36-86°F
The Rapid Response™ test device is manufactured in Canada by BTNX Inc. and was authorized for use by Health Canada on February 19, 2021.
Buy the BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device for Your Workplace
If your company or organization is interested in rapid testing solutions, contact us today for help procuring the BTNW Rapid Response™ test device or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.